Bioxera Pharma

BioXera Pharma specializes in the development of innovative processes for a wide range of products. The business comprises of manufacturing and sales of APIs and intermediates in both domestic and international markets, including the regulated markets. With a strong R&D backbone, word class infrastructure, headed by a team of technocrats, BioXera has established a large portfolio of molecules in commercial production along with several more in the pipeline. Today, BioXera Pharma operates a state-of- the art API manufacturing facility at Ambernath, Maharashtra spread over a plot area of 110,000 sq.ft. With the ability to handle complex chemical synthesis, BioXera has built up strength in the development, process optimisation and cGMP production of APIs and intermediates. Currently, we export API and intermediates to over 27 countries, and are poised to enter more shortly.